AMF Tjanstepension AB Has $12.48 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

AMF Tjanstepension AB raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 23.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 42,402 shares of the biotechnology company’s stock after buying an additional 8,061 shares during the quarter. AMF Tjanstepension AB’s holdings in Axon Enterprise were worth $12,476,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Avantax Advisory Services Inc. grew its position in Axon Enterprise by 0.8% in the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after acquiring an additional 40 shares during the period. Brookstone Capital Management grew its position in Axon Enterprise by 5.1% in the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares during the period. Envestnet Portfolio Solutions Inc. grew its position in Axon Enterprise by 1.1% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after acquiring an additional 43 shares during the period. UMB Bank n.a. grew its position in Axon Enterprise by 11.0% in the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after acquiring an additional 44 shares during the period. Finally, Burns Matteson Capital Management LLC grew its position in Axon Enterprise by 6.7% in the second quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock valued at $215,000 after acquiring an additional 46 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares in the company, valued at $498,282.49. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Julie A. Cullivan sold 478 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $286.04, for a total transaction of $136,727.12. Following the completion of the sale, the director now directly owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 308 shares of the business’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 89,447 shares of company stock valued at $27,684,677. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 18.4 %

NASDAQ:AXON traded up $54.24 during mid-day trading on Wednesday, hitting $349.24. The company had a trading volume of 3,406,496 shares, compared to its average volume of 517,385. Axon Enterprise, Inc. has a fifty-two week low of $175.59 and a fifty-two week high of $367.95. The business’s fifty day moving average is $296.14 and its two-hundred day moving average is $294.62. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. The firm has a market cap of $26.36 billion, a P/E ratio of 102.12, a P/E/G ratio of 6.59 and a beta of 0.95.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. During the same quarter in the prior year, the firm posted $0.80 earnings per share. The company’s quarterly revenue was up 34.5% on a year-over-year basis. As a group, research analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Barclays increased their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Robert W. Baird increased their target price on Axon Enterprise from $355.00 to $360.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, JMP Securities restated a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a report on Wednesday. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $348.08.

Check Out Our Latest Stock Analysis on Axon Enterprise

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.